NFKB1 and glioblastoma: EVs induced mesenchymal transition and therapeutic resistance in GBM through NF-κB/STAT3 signaling 35.Small EVs originate from the endosomal system through invagination of the plasma membrane and early endosome, which then mature into MVBs.